» Authors » Gila Kazimirsky

Gila Kazimirsky

Explore the profile of Gila Kazimirsky including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 580
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nizar R, Cazacu S, Xiang C, Krasner M, Barbiro-Michaely E, Gerber D, et al.
Cells . 2023 Aug; 12(15). PMID: 37566001
Glioblastoma (GBM) is the most common and aggressive primary brain tumor. GBM contains a small subpopulation of glioma stem cells (GSCs) that are implicated in treatment resistance, tumor infiltration, and...
2.
Eswaran L, Kazimirsky G, Yehuda R, Byk G
Pharmaceutics . 2023 Mar; 15(3). PMID: 36986821
We have developed new formulations of nanohydrogels (NHGs) complexed with DNA devoid of cell toxicity, which, together with their tuned sizes, makes them of great interest for delivering DNA/RNA for...
3.
Eswaran L, Kazimirsky G, Byk G
Pharmaceutics . 2023 Feb; 15(2). PMID: 36839655
The advent of protein expression using m-RNA applied lately for treating the COVID pandemic, and gene editing using CRISPR/Cas9 technology for introducing DNA sequences at a specific site in the...
4.
Unterman I, Bloch I, Cazacu S, Kazimirsky G, Ben-Zeev B, Berman B, et al.
Elife . 2021 Aug; 10. PMID: 34355696
Inactivating mutations in the Methyl-CpG Binding Protein 2 (MECP2) gene are the main cause of Rett syndrome (RTT). Despite extensive research into MECP2 function, no treatments for RTT are currently...
5.
Peeri H, Shalev N, Vinayaka A, Nizar R, Kazimirsky G, Namdar D, et al.
Cancers (Basel) . 2021 Apr; 13(7). PMID: 33916466
Glioblastoma multiforme (GBM) is the most lethal subtype of glioma. is used for the treatment of various medical conditions. Around 150 phytocannabinoids have been identified in , among them Δ-9-tetrahydrocannabinol...
6.
Morgoulis D, Berenstein P, Cazacu S, Kazimirsky G, Dori A, Barnea E, et al.
Cell Death Dis . 2019 Jan; 10(2):82. PMID: 30692507
Duchenne muscular dystrophy (DMD) is a progressive, lethal, X-linked disease of skeletal and cardiac muscles caused by mutations in the dystrophin gene. Loss of dystrophin leads to muscle fiber damage...
7.
Bier A, Berenstein P, Kronfeld N, Morgoulis D, Ziv-Av A, Goldstein H, et al.
Biomaterials . 2018 May; 174:67-78. PMID: 29783118
Duchenne muscular dystrophy (DMD) is a degenerative lethal, X-linked disease of skeletal and cardiac muscles caused by mutations in the dystrophin gene. Cell therapy using different cell types, including mesenchymal...
8.
Shwartz A, Betzer O, Kronfeld N, Kazimirsky G, Cazacu S, Finniss S, et al.
Theranostics . 2017 Aug; 7(10):2690-2703. PMID: 28819456
Recent studies have proposed that abnormal glutamatergic neurotransmission and glial pathology play an important role in the etiology and manifestation of depression. It was postulated that restoration of normal glutamatergic...
9.
Kazimirsky G, Jiang W, Slavin S, Ziv-Av A, Brodie C
Stem Cell Res Ther . 2016 Oct; 7(1):149. PMID: 27724977
Background: Newcastle disease virus (NDV) is an avian paramyxovirus, which selectively exerts oncolytic effects in cancer cells. Mesenchymal stem cells (MSCs) have been reported to affect tumor growth and deliver...
10.
Shilo M, Berenstein P, Dreifuss T, Nash Y, Goldsmith G, Kazimirsky G, et al.
Nanoscale . 2015 Nov; 7(48):20489-96. PMID: 26583784
Diabetes mellitus is a chronic metabolic disease, characterized by high blood glucose levels, affecting millions of people around the world. Currently, the main treatment for diabetes requires multiple daily injections...